{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:18:51Z","timestamp":1776853131543,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2807,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1111\/jth.12867","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T03:07:08Z","timestamp":1423019228000},"page":"592-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance"],"prefix":"10.1016","volume":"13","author":[{"given":"D.J.","family":"Groeneveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"van Bekkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Eikenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12867_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/jth.12867_bb0015","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI107471","article-title":"Synthesis of antihemophilic factor antigen by cultured human endothelial cells","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12867_bb0020","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1172\/JCI108846","article-title":"Synthesis of factor\u00a0VIII antigen by cultured guinea pig megakaryocytes","volume":"60","author":"Nachman","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12867_bb0025","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in\u00a0vivo: effect of experimental endotoxemia and administration of 1\u2010deamino\u20108\u2010D\u2010arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0030","first-page":"89","article-title":"Factor\u00a0VIII and factor\u00a0IX in a twin population. Evidence for a major effect of ABO locus on factor\u00a0VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1111\/jth.12867_bb0035","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1016\/S0021-9258(19)50338-6","article-title":"Structures of the asparagine\u2010linked oligosaccharide chains of human von Willebrand factor","volume":"267","author":"Matsui","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12867_bb0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1055\/s-0038-1665305","article-title":"Factor\u00a0VIII levels and blood group antigens","volume":"50","author":"McCallum","year":"1983","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0045","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biological function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/jth.12867_bb0050","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood-2005-02-0792","article-title":"Bombay phenotype is associated with reduced plasma\u2010VWF levels and an increased susceptibility to ADAMTS13 proteolysis","volume":"106","author":"O'Donnell","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/hq0202.103997","article-title":"Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels","volume":"22","author":"O'Donnell","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12867_bb0060","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1160\/TH06-09-0549","article-title":"ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens","volume":"97","author":"Morelli","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0065","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","article-title":"von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis","volume":"4","author":"Nossent","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0070","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide and FVIII in the characterization of type\u00a01 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000054087","article-title":"Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens","volume":"37","author":"O'Donnell","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1111\/jth.12867_bb0080","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post\u2010DDAVP in Type\u00a01 von Willebrand disease: is it a potential pathogenic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0085","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0090","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type\u00a01 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0100","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1538-7836.2007.02588.x","article-title":"von Willebrand factor\/factor\u00a0VIII concentrate (Haemate\u00ae\u00a0P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery","volume":"5","author":"Lethagen","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0105","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in\u00a0vivo survival of von Willebrand factor","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12867_bb0110","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1074\/jbc.M010805200","article-title":"Murine equivalent of the human histo\u2010blood group ABO gene is acis\u2010AB gene and encodes a glycosyltransferase with both A and B transferase activity","volume":"276","author":"Yamamoto","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12867_bb0115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/hum.2008.089","article-title":"Induction of human blood group\u00a0A antigen expression on mouse cells, using lentiviral gene transduction","volume":"21","author":"Fan","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1111\/jth.12867_bb0120","doi-asserted-by":"crossref","first-page":"e1002942","DOI":"10.1371\/journal.ppat.1002942","article-title":"ABO blood groups influence macrophage\u2010mediated phagocytosis of Plasmodium falciparum\u2010infected erythrocytes","volume":"8","author":"Wolofsky","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1111\/jth.12867_bb0125","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1538-7836.2009.03453.x","article-title":"Species\u2010dependent variability of ADAMTS13\u2010mediated proteolysis of human recombinant von Willebrand factor","volume":"7","author":"Varadi","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0130","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13\u2010deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12867_bb0135","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood.V88.5.1692.1692","article-title":"Clearance of normal and type\u00a02A von Willebrand factor in the rat","volume":"88","author":"Stoddart","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0140","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.12867_bb0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jth.12226","article-title":"Clearance of von Willebrand factor","volume":"11","author":"Casari","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12867_bb0150","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma\u2010free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12867","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362208401X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362208401X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12867\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:10:50Z","timestamp":1761534650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362208401X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S153878362208401X"],"URL":"https:\/\/doi.org\/10.1111\/jth.12867","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}